Hardy Reed’s Privia Health PRVA Stock Holding History

Hardy Reed’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,813	Closed	-$203K	–	256
2025 Q2	$203K	Buy	+8,813	New	+$204K	0.02%	243

Other funds holding PRVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hardy Reed's PRVA Position: Q3 2025 in Review

Hardy Reed sold out of Privia Health (PRVA) in Q3 2025, closing a stake of 8,813 shares — an estimated $203K sold.

Hardy Reed first reported a position in PRVA in Q2 2025 and held it in 1 quarter. The position peaked at $203K in Q2 2025. 259 funds tracked by Wall St. Rank hold PRVA as of Q3 2025.

Hardy Reed reported no remaining Privia Health position as of Q3 2025 after selling out during the quarter.
Hardy Reed sold 8,813 Privia Health shares in Q3 2025, an estimated $203K.
Hardy Reed first reported a position in Privia Health in Q2 2025 and held it in 1 quarter.
Hardy Reed's Privia Health position peaked at $203K in Q2 2025.
259 funds tracked by Wall St. Rank held Privia Health as of Q3 2025.

Based on Hardy Reed's 13F filing for Q3 2025, filed 7 Nov 2025.